Pharmaceutical CDMO 2.0 Market Size & Share, Growth Report 2035

Pharmaceutical CDMO 2.0 Market size was valued at USD 173.9 billion in 2025 and is projected to exceed USD 386 billion by the end of 2035, expanding at over 8.3% CAGR during the forecast period i.e., between 2026-2035. North America industry is projected to account for the largest share, at 41.6% by 2035, owing to a high concentration of large pharmaceutical and biotechnology companies and an advanced regulatory framework.